These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 11739439)
1. A novel insulinoma tumor suppressor gene locus on chromosome 22q with potential prognostic implications. Wild A; Langer P; Ramaswamy A; Chaloupka B; Bartsch DK J Clin Endocrinol Metab; 2001 Dec; 86(12):5782-7. PubMed ID: 11739439 [TBL] [Abstract][Full Text] [Related]
2. Indications for a tumor suppressor gene at 22q11 involved in the pathogenesis of ependymal tumors and distinct from hSNF5/INI1. Kraus JA; de Millas W; Sörensen N; Herbold C; Schichor C; Tonn JC; Wiestler OD; von Deimling A; Pietsch T Acta Neuropathol; 2001 Jul; 102(1):69-74. PubMed ID: 11547953 [TBL] [Abstract][Full Text] [Related]
3. [Frequent loss of heterozygosity at MEN-1 gene and chromosome 22q in insulinomas and its significance]. Jiang WJ; Liu TH; Chen J; Gao J; Wu SF; Chen YJ Zhonghua Yi Xue Za Zhi; 2004 Oct; 84(20):1705-9. PubMed ID: 15569430 [TBL] [Abstract][Full Text] [Related]
4. Heterozygosity loss at 22q and lack of INI1 gene mutation in gastrointestinal stromal tumor. Yamamoto H; Kohashi K; Tsuneyoshi M; Oda Y Pathobiology; 2011; 78(3):132-9. PubMed ID: 21613800 [TBL] [Abstract][Full Text] [Related]
5. hSNF5/INI1 inactivation is mainly associated with homozygous deletions and mitotic recombinations in rhabdoid tumors. Rousseau-Merck MF; Versteege I; Legrand I; Couturier J; Mairal A; Delattre O; Aurias A Cancer Res; 1999 Jul; 59(13):3152-6. PubMed ID: 10397258 [TBL] [Abstract][Full Text] [Related]
6. Novel germ-line deletion of SNF5/INI1/SMARCB1 gene in neonate presenting with congenital malignant rhabdoid tumor of kidney and brain primitive neuroectodermal tumor. Kusafuka T; Miao J; Yoneda A; Kuroda S; Fukuzawa M Genes Chromosomes Cancer; 2004 Jun; 40(2):133-9. PubMed ID: 15101046 [TBL] [Abstract][Full Text] [Related]
7. Chromosome 22q in pancreatic endocrine tumors: identification of a homozygous deletion and potential prognostic associations of allelic deletions. Wild A; Langer P; Celik I; Chaloupka B; Bartsch DK Eur J Endocrinol; 2002 Oct; 147(4):507-13. PubMed ID: 12370114 [TBL] [Abstract][Full Text] [Related]
8. Frequent loss of heterozygosity at chromosome 3p14.2-3p21 in human pancreatic islet cell tumours. Nikiforova MN; Nikiforov YE; Biddinger P; Gnepp DR; Grosembacher LA; Wajchenberg BL; Fagin JA; Cohen RM Clin Endocrinol (Oxf); 1999 Jul; 51(1):27-33. PubMed ID: 10468962 [TBL] [Abstract][Full Text] [Related]
9. Chromosome 1q loss of heterozygosity frequently occurs in sporadic insulinomas and is associated with tumor malignancy. Yang YM; Liu TH; Chen YJ; Jiang WJ; Qian JM; Lu X; Gao J; Wu SF; Sang XT; Chen J Int J Cancer; 2005 Nov; 117(2):234-40. PubMed ID: 15900598 [TBL] [Abstract][Full Text] [Related]
10. Frequent deletion of hSNF5/INI1, a component of the SWI/SNF complex, in chronic myeloid leukemia. Grand F; Kulkarni S; Chase A; Goldman JM; Gordon M; Cross NC Cancer Res; 1999 Aug; 59(16):3870-4. PubMed ID: 10463572 [TBL] [Abstract][Full Text] [Related]
11. Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer. Versteege I; Sévenet N; Lange J; Rousseau-Merck MF; Ambros P; Handgretinger R; Aurias A; Delattre O Nature; 1998 Jul; 394(6689):203-6. PubMed ID: 9671307 [TBL] [Abstract][Full Text] [Related]
12. Establishment of a cell line from a malignant rhabdoid tumor of the liver lacking the function of two tumor suppressor genes, hSNF5/INI1 and p16. Kuroda H; Moritake H; Sawada K; Kuwahara Y; Imoto I; Inazawa J; Sugimoto T Cancer Genet Cytogenet; 2005 Apr; 158(2):172-9. PubMed ID: 15796965 [TBL] [Abstract][Full Text] [Related]
13. SMARCB1/INI1 tumor suppressor gene is frequently inactivated in epithelioid sarcomas. Modena P; Lualdi E; Facchinetti F; Galli L; Teixeira MR; Pilotti S; Sozzi G Cancer Res; 2005 May; 65(10):4012-9. PubMed ID: 15899790 [TBL] [Abstract][Full Text] [Related]
14. Loss of heterozygosity on chromosome 22q in gastrointestinal stromal tumors (GISTs): a study on 50 cases. Lasota J; Wozniak A; Kopczynski J; Dansonka-Mieszkowska A; Wasag B; Mitsuhashi T; Sarlomo-Rikala M; Lee JR; Schneider-Stock R; Stachura J; Limon J; Miettinen M Lab Invest; 2005 Feb; 85(2):237-47. PubMed ID: 15580284 [TBL] [Abstract][Full Text] [Related]
15. Absence of mutations on the SNF5 gene in hematological neoplasms with chromosome 22 abnormalities. Mori N; Inoue K; Okada M; Motoji T Acta Haematol; 2011; 126(2):69-75. PubMed ID: 21494030 [TBL] [Abstract][Full Text] [Related]
16. Evidence for two tumor suppressor loci associated with proximal chromosome 9p to q and distal chromosome 9q in bladder cancer and the initial screening for GAS1 and PTC mutations. Simoneau AR; Spruck CH; Gonzalez-Zulueta M; Gonzalgo ML; Chan MF; Tsai YC; Dean M; Steven K; Horn T; Jones PA Cancer Res; 1996 Nov; 56(21):5039-43. PubMed ID: 8895761 [TBL] [Abstract][Full Text] [Related]
17. INI1 mutations in meningiomas at a potential hotspot in exon 9. Schmitz U; Mueller W; Weber M; Sévenet N; Delattre O; von Deimling A Br J Cancer; 2001 Jan; 84(2):199-201. PubMed ID: 11161377 [TBL] [Abstract][Full Text] [Related]
18. Mutational analysis of INI1 in sporadic human brain tumors. Weber M; Stockhammer F; Schmitz U; von Deimling A Acta Neuropathol; 2001 May; 101(5):479-82. PubMed ID: 11484819 [TBL] [Abstract][Full Text] [Related]
19. Genome-wide search for loss of heterozygosity in transgenic mouse tumors reveals candidate tumor suppressor genes on chromosomes 9 and 16. Dietrich WF; Radany EH; Smith JS; Bishop JM; Hanahan D; Lander ES Proc Natl Acad Sci U S A; 1994 Sep; 91(20):9451-5. PubMed ID: 7937788 [TBL] [Abstract][Full Text] [Related]
20. Absence of hSNF5/INI1 mutation in human lung cancer. Manda R; Kohno T; Hamada K; Takenoshita S; Kuwano H; Yokota J Cancer Lett; 2000 May; 153(1-2):57-61. PubMed ID: 10779630 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]